United States v. Bioclinical Systems, Inc.
United States District Court for the District of Maryland
666 F. Supp. 82 (1987)

- Written by Mary Phelan D'Isa, JD
Facts
The Food and Drug Administration (FDA) brought an enforcement action under the Federal Food, Drug, and Cosmetic Act (FDCA) against Bioclinical Systems, Inc. (BSI) (defendant), the manufacturer of plated culture media. The FDA alleged that BSI failed to meet the FDA’s Good Manufacturing Practices, (GMPs)—as dictated by the FDA Office of Compliance—regarding a sterility assurance level (SAL) of 0.1 percent. BSI challenged the requirement, which had been adopted as the de facto standard ever since a draft set Inspection Guidelines incorporating the standard was issued by the FDA’s Center for Devices and Radiological Health.
Rule of Law
Issue
Holding and Reasoning (Motz, J.)
What to do next…
Here's why 964,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 47,500 briefs, keyed to 1,006 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.
- AI-generated podcast version of every brief — listen on the go, between classes, or whenever reading isn’t an option. New
Understand your casebook readings in seconds
Use our case briefs to comprehend your casebook readings faster, supplement your notes and outlines, and outshine your peers in class.
Get instant access to over 47,500+ expert-written case briefs in a searchable database keyed to 1,006 law school casebooks.

